|
![]() |
|
|
Phenytoin
drug data and news
Phenytoin drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.
|
| Generic name | Phenytoin | ||
| Brand Names/Synonyms | Aleviatin; Antisacer; Auranile; CCRIS 515; Causoin; Cerebyx; Citrullamon; Citrulliamon; Comital; Comitoina; Convul; DPH; Danten; Dantinal; Dantoinal; Dantoinal Klinos; Dantoine; Denyl; Di-Hydan; Di-Lan; Di-Phetine; Didan Tdc 250; Difenilhidantoina; Difenilhidantoina [Spanish]; Difenin; Difetoin; Difhydan; Dihycon; Dihydantoin; Dilabid; Dilantin; Dilantin Acid; Dilantin-125; Dilantine; Dillantin; Dintoin; Dintoina; Diphantoin; Diphantoine; Diphedal; Diphedan; Diphenat; Diphenin; Diphenine; Diphentoin; Diphentyn; Diphenylan; Diphenylan Sodium; Diphenylhydantoin; Diphenylhydantoine; Diphenylhydantoine [French]; Diphenylhydatanoin; Ditoinate; Ekko; Ekko Capsules; Elepsindon; Enkelfel; Epamin; Epanutin; Epasmir "5"; Epasmir &Quot;5&Quot;; Epasmir 5; Epdantoin Simple; Epdantoine Simple; Epelin; Epifenyl; Epihydan; Epilan; Epilan D; Epilan-D; Epilantin; Epinat; Epised; Eptal; Eptoin; Extended Phenytoin Sodium; Fenantoin; Fenantoin Mn Pharma; Fenidantoin "S"; Fenidantoin &Quot;S&Quot;; Fenidantoin S; Fenitoina; Fenitoina [Inn-Spanish]; Fentoin; Fenylepsin; Fenytoin Dak; Fenytoine; Fosphenytoin; Hidan; Hidantal; Hidantilo; Hidantina; Hidantina Senosian; Hidantina Vitoria; Hidantomin; Hindatal; Hydantal; Hydantin; Hydantoin; Hydantoinal; Hydantol; Ictalis Simple; Idantoil; Idantoin; Iphenylhydantoin; Kessodanten; Labopal; Lehydan; Lepitoin; Lepsin; Mesantoin; Minetoin; NSC 8722; Neos-Hidantoina; Neosidantoina; Novantoina; Novophenytoin; Om Hidantoina Simple; Om-Hydantoine; Oxylan; Phanantin; Phanatine; Phenatine; Phenatoine; Phenhydan; Phenhydanin; Phenitoin; Phentoin; Phentytoin; Phenytex; Phenytoin; Phenytoin Awd; Phenytoin Sodium; Phenytoin-Gerot; Phenytoine; Phenytoine [Inn-French]; Phenytoinum [Inn-Latin]; Prompt Phenytoin Sodium; Ritmenal; Saceril; Sanepil; Silantin; Sinergina; Sodanthon; Sodantoin; Sodanton; Sodium; Solantin; Solantoin; Solantyl; Sylantoic; TOIN; Tacosal; Thilophenyl; Toin Unicelles; Zentronal; Zentropil | ||
| Indication | For the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery | ||
| Sponsored links | Description | Not Available | |
| Pharmacology | Phenytoin is an antiepileptic drug which can be useful in the treatment of epilepsy. The primary site of action appears to be the motor cortex where spread of seizure activity is inhibited. Possibly by promoting sodium efflux from neurons, Phenytoin tends to stabilize the threshold against hyperexcitability caused by excessive stimulation or environmental changes capable of reducing membrane sodium gradient. This includes the reduction of post-tetanic potentiation at synapses. Loss of post-tetanic potentiation prevents cortical seizure foci from detonating adjacent cortical areas. Phenytoin reduces the maximal activity of brain stem centers responsible for the tonic phase of tonic-clonic (grand mal) seizures. | ||
| Mechanism Of Action | Phenytoin acts on sodium channels on the neuronal cell membrane, limiting the spread of seizure activity and reducing seizure propagation. The antiarrhythmic actions are mediated through effects on sodium channels in Purkinje fibers. | ||
| Phenytoin News (When available) |
New Study Shows Initial Treatment With 800 mg/day Imatinib ... May 15, 2006 Anticonvulsant Treatment for Psychiatric and Seizure Indications ... May 4, 2006 Lamotrigine Improves Depressed Mood in Women With Epilepsy ... May 11, 2006 Self-Mutilation of Fingers After Cervical Spinal Cord Injury May 9, 2006 Neuropathic Pain: An Update on Effective Management Strategies May 5, 2006 Halozyme Therapeutics Reports First Quarter 2006 Financial Results May 10, 2006 Insulin-dependent Diabetes Mellitus Apr 30, 2006 Can you diagnose cancer without a biopsy? Apr 30, 2006 | ||
| Dosage Forms | CAPSULE; LIQUID; SOLUTION; SUSPENSION; TABLET | ||
| Drug_Category | Anticonvulsants; Hydantoins; ATC:N03AB02; ATC:N03AB04; ATC:N03AB05 | ||
| Absorption | Not Available | ||
| Interactions |
-->Interactions for Phenytoin: There are many drugs which may increase or decrease phenytoin levels or which phenytoin may affect. Serum level determinations for phenytoin are especially helpful when possible drug interactions are suspected. The most commonly occurring drug interactions are listed below: 1. Drugs which may increase phenytoin serum levels include: acute alcohol intake, amiodarone, chloramphenicol, chlordiazepoxide, diazepam, dicumarol, disulfiram, estrogens, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone. 2. Drugs which may decrease phenytoin serum levels include: carbamazepine, chronic alcohol abuse, reserpine, and sucralfate. Moban brand of Molindone Hydrochloride contains calcium ions which interfere with the absorption of phenytoin. Ingestion times of phenytoin and antacid preparations containing calcium should be staggered in patients with low serum phenytoin levels to prevent absorption problems. 3. Drugs which may either increase or decrease phenytoin serum levels include: phenobarbital, sodium valproate, and valproic acid. Similarly, the effect of phenytoin on phenobarbital, valproic acid and sodium valproate serum levels is unpredictable. 4. Although not a true drug interaction, tricyclic antidepressants may precipitate seizures in susceptible patients and phenytoin dosage may need to be adjusted. 5. Drugs whose efficacy is impaired by phenytoin include: corticosteroids, coumarin anticoagulants, digitoxin, doxycycline, estrogens, furosemide, oral contraceptives, quinidine, rifampin, theophylline, vitamin D. Drug/Laboratory Test Interactions Phenytoin may cause decreased serum levels of protein-bound iodine (PBI). It may also produce lower than normal values for dexamethasone or metyrapone tests. Phenytoin may cause increased serum levels of glucose, alkaline phosphatase, and gamma glutamyl transpeptidase (GGT). | ||
| Toxicity | Side effects include nystagmus, ataxia, and dysarthria, tremor, hyperreflexia, lethargy, slurred speech, nausea, vomiting; LD50=92mg/kg (I.V in mice) | ||
| Organisms Affected | Humans and other mammals | ||
| Chemical IUPAC Name | 5,5-diphenylimidazolidine-2,4-dione | ||
| Chemical Formula | C15H12N2O2 | ||
| Molecular Weight | 252.268 g/mol | ||
| Smiles String | C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3 | ||
| Melting Point | 286 °C | ||
| Water Solubility | 0.019 mg/mL | ||
| State | Solid | ||
| LogP/Hphobicity | 2.241 | ||
| Isoelectric Point | 8.33 | ||
| Biotransformation | Primarily hepatic | ||
| Half Life | 22 hours | ||
| Protein Binding [%] | highly protein bound | ||
| RxList Link | RXlist | ||
| Sponsored links | |||
| Drug Reference |
http://www.drugs.com/cons/Phenytoin.html http://www.rxlist.com/cgi/generic/phenyt.htm http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/dil1136.shtml | ||
| Drug Type | Approved Drug | ||
| Accession No | APRD00241 | ||
| CAS Registry Number | 57-41-0 | ||
| KEGG Compound ID | C07443 | ||
| PubChem ID | SID:148821 | ||
| PharmGKB ID | PA450947 | ||
| SwissProt ID | Not Available | ||
| GenBank ID | Not Available | ||
| Drug ID Number [DIN] | 780626 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |